Truist Financial Corp F Star Therapeutics, Inc. Transaction History

Truist Financial Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 22, 2022	SELL	$2.77 - $5.36 $219,084 - $423,933	-79,092 Closed	0 $0
Q3 2021 Nov 05, 2021	BUY	$5.2 - $8.42 $171,600 - $277,860	33,000 Added 71.6%	79,092 $579,000
Q2 2021 Aug 16, 2021	BUY	$6.57 - $10.71 $236,520 - $385,560	36,000 Added 356.72%	46,092 $396,000
Q1 2021 May 17, 2021	BUY	$7.09 - $13.84 $71,552 - $139,673	10,092 New	10,092 $0

44.7K

Ticker FSTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,584,700
Description
F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck c...

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Truist Financial Corp with notifications on news.